![](/img/cover-not-exists.png)
T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein
Julien Laurent, Cedric Touvrey, Silke Gillessen, Magali Joffraud, Manuela Vicari, Caroline Bertrand, Stefano Ongarello, Bernd Liedert, Elisa Gallerani, Joachim Beck, Aurelius Omlin, Cristiana Sessa, SVolume:
11
Language:
english
DOI:
10.1186/1479-5876-11-5
Date:
December, 2013
File:
PDF, 1.17 MB
english, 2013